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ABSTRACT The coordination of long chain fatty acid (LCFA) transport across the mitochondrial membrane (VPAL) with
subsequent oxidation rate through -oxidation and the tricarboxylic acid (TCA) cycle (Vtca) has been difficult to characterize
in the intact heart. Kinetic analysis of dynamic 13C-NMR distinguished these flux rates in isolated rabbit hearts. Hearts were
perfused in a 9.4 T magnet with either 0.5 mM [2,4,6,8,10,12,14,16-13C8] palmitate (n  4), or 0.5 mM
13C-labeled palmitate
plus 0.08 mM unlabeled butyrate (n  4). Butyrate is a short chain fatty acid (SCFA) that bypasses the LCFA transporters of
mitochondria. In hearts oxidizing palmitate alone, the ratio of VTCA to VPAL was 8:1. This is consistent with one molecule of
palmitate yielding eight molecules of acetyl-CoA for the subsequent oxidation through the TCA cycle. Addition of butyrate
elevated this ratio; VTCA/VPAL  12:1 due to an SCFA-induced increase in VTCA of 43% (p  0.05). However, SCFA oxidation
did not significantly reduce palmitate transport into the mitochondria: VPAL  1.0  0.2 mol/min/g dw with palmitate alone
versus 0.9 0.1 with palmitate plus butyrate. Thus, the products of -oxidation are preferentially channeled to the TCA cycle,
away from mitochondrial efflux via carnitine acetyltransferase.
INTRODUCTION
This work is the first dynamic measurement of long chain
fatty acid (LCFA) transport and oxidation in the mitochon-
dria of intact, beating hearts via 13C- NMR spectroscopy.
Fatty acids are an important source of energy in the heart,
skeletal muscle, and liver. In heart alone, 60% of the
energy requirements are met by the oxidation of fatty acids
(Belke et al., 1999; Goodwin and Taegtmeyer, 1999), and
this demand can increase under conditions of fasting and
diabetes (McGarry et al., 1989). Significant changes or
defects in fatty acid oxidation have been reported for con-
ditions of hypertrophy, ischemic heart disease, diabetic car-
diomyopathies, and congenital defects (Barger and Kelly,
1999; Brivet et al., 1999; Kantor et al., 1999; Lopaschuk et
al., 1994); yet little information exists from intact hearts
regarding the coordination of relative fluxes for fatty acid
transport into the cell and mitochondria, and oxidation via
-oxidation and the tricarboxylic acid (TCA) cycle. This
study addresses the problem using a novel method that
provides on-line monitoring of the LCFA metabolism using
a previously unavailable 13C-enriched fatty acid,
[2,4,6,8,10,12,14,16-13C8] palmitate.
The metabolism of LCFA begins with transport across
the cell membrane by the fatty acid transporters. Although
a number of fatty acid transporters at the sarcolemma have
been identified, it has yet to be determined what kinetic
effects these transporters have on LCFA metabolism in the
cardiomyocyte (Lopaschuk et al., 1994). Once in the cy-
tosol, LCFA binds to the fatty acid binding protein (FABP),
or is converted to an acyl-CoA ester, transported across the
mitochondrial membrane by the carnitine shuttle, and ca-
tabolism through -oxidation to produce acetyl-CoA.
Acetyl-Co is then oxidized through the TCA cycle. Al-
though LCFA metabolism could arguably be regulated by
any of the enzymes involved in the pathway, it is generally
presumed that the rate-determining step of LCFA metabo-
lism is the transport of the fatty acid across the mitochondria
by the carnitine shuttle (Lopaschuk et al., 1994; McGarry
and Brown, 1997; Van Der Vusse et al., 1992). In this study
we quantify this rate-determining flux and distinguish it
from the rate of TCA cycle activity.
Earlier studies have provided information on fatty acid
oxidation in healthy and diseased intact heart (Belke et al.,
1999; Crass et al., 1969; Goodwin and Taegtmeyer, 1999;
Neely at al., 1969; Vanoverschelde et al., 1993). That work
was based on either oxygen consumption rates from arterial
and venous sampling, PET detection of net label accumu-
lation, or 14CO2 release into the extracellular space. Al-
though the methods provided valuable insight into fatty acid
metabolism, they could not distinguish specific metabolic
pathways in the beating heart. 13C-NMR provides a means
to monitor specific pathways in intact functioning tissue by
directly observing the dynamic labeling of intermediate
metabolite pools (Lewandowski, 1992; Malloy et al., 1989;
Robitaille et al., 1993; Weiss et al., 1992).
Until recently, dynamic NMR studies of the whole heart
had been limited by the use of labeled substrates, which
were both non-physiological and excluded LCFA metabo-
lism. The use of l3C-labeled palmitate alleviates this previ-
ous limitation. In this study, the link between LCFA entry
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into the mitochondria and TCA cycle flux was elucidated in
the presence of palmitate and an alternative short chain fatty
acid (SCFA) to provide the first glimpse of fatty acid uptake
and transport kinetics in relation to oxidative flux rates in
functioning heart.
MATERIALS AND METHODS
Experimental protocol
Animal use conformed to the “Guide for the Care and Use of Laboratory
Animals” (National Research Council, revised 1996). Hearts from Dutch
Belted rabbits were isolated and perfused in retrograde fashion as previ-
ously described (Johnston and Lewandowski, 1991; Lewandowski, 1992;
Neely et al., 1967; O’Donnell et al., 1998). Left ventricular developed
pressure (LVDP), heart rate (HR), and myocardial oxygen consumption
(MVO2) were monitored throughout experiments. All hearts were initially
perfused with buffer containing 5 mM unlabeled glucose, and coronary
effluent was discarded. At the start of each protocol, a 31P-NMR spectrum
was acquired to confirm the energetic stability of the preparation. The
buffer supply was then switched from media containing glucose to that
containing either 0.5 mM unlabeled palmitate (n 4) or 0.5 mM unlabeled
palmitate plus 0.08 mM unlabeled butyrate (n  4). Butyrate is a four-
carbon SCFA that enters -oxidation, but bypasses the transport of LCFA
into the mitochondria. The potassium salt of palmitic acid was complexed
to 3% albumin and dialyzed before use (Johnston and Lewandowski,
1991). Hearts were perfused with unlabeled media for 10 min, and back-
ground 13C-NMR signals of naturally abundant (1.1%) 13C were acquired
for digital subtraction of background signal.
At the start of the isotope enrichment protocol the buffer supply was then
switched to recirculated media containing 0.5 mM [2,4,6,8,10,12,14,16-13C8]
palmitate alone, or with 0.08 mM unlabeled butyrate. Sequential 13C-NMR
spectra (2.6-min blocks) were acquired for 40 min. The hearts were than
removed from the magnet, freeze-clamped, and prepared for in vitro analysis
of metabolite content and isotopic enrichment. 31P- and 13C-NMR measure-
ments were acquired at 9.4 T by methods described extensively elsewhere
(O’Donnell et al., 1998; Yu et al., 1995, 1997).
Tissue chemistry
Perchloric acid extracts were obtained from ventricle as previously de-
scribed (Lewandowski, 1992). Glutamate, -ketoglutarate, citrate, and
aspartate concentrations were determined from spectrophotometric and
fluorometric techniques (Bergmeyer, 1974). The remainder of the extract
was lyophilized and resuspended in D2O for high-resolution NMR analysis
(O’Donnell et al., 1998). From frozen tissue samples, lipids were extracted
and separated as described by Bowyer and King (1977). Thin-layer chro-
matography (TLC) was used to isolated triglycerides for GC-MS analysis.
Total tissue tri, di, and monoglyceride content was determined by measur-
ing glycerol release following saponification of the isolated lipids (Lopas-
chuk et al., 1986).
GC-MS analyses of extracted fatty acid methyl esters were performed
on a Hewlett-Packard 1 GC/MS. For GC-MS quantitation, on-line com-
puter-controlled electro-ionization detection was used.
Isotope-labeling scheme
13C-labeled palmitate is transported across the mitochondrial membrane by
the carnitine shuttle (CPT1, CPT2, and CAT), is oxidized through -oxi-
dation, and contributes to the formation of acetyl-CoA enriched at the
second carbon position. Acetyl-CoA enters the TCA cycle, and subse-
quently enriches the C4 carbon position of -ketoglutarate (Fig. 1). Chem-
ical exchange between -ketoglutarate and glutamate pools results in
labeling at the 4-carbon of glutamate. Oxidation of -ketoglutarate in the
mitochondrial matrix produces succinate, shifting the label to the 2- or
3-carbon position with equal probability. As the carbon label recycles to
the first span of the TCA cycle, the recycled label then becomes incorpo-
rated at the 2- or 3-carbon of -ketoglutarate, and ultimately glutamate
(Chance et al., 1983). The rate of isotope exchange between these meta-
bolic compartments has been previously reported (LaNoue et al., 1970; Yu
et al., 1995).
Kinetic model and analysis
An existing set of differential equations that describes the concentration
history of the 13C in each metabolite and developed in our laboratory was
modified to include the additional, rate-determining components of LCFA
uptake into the mitochondria. The original model has been used extensively
to examine both TCA cycle flux and metabolite transport between the
mitochondria and cytosol (O’Donnell et al., 1998; Yu et al., 1995, 1997) in
heart.
The inclusion of LCFA metabolism requires the addition of a 10th
compartment that reflects the rate-determining transport of LCFA across
the mitochondrial membrane and the subsequent accumulation of labeled
fatty acid intermediates in the mitochondria. Fig. 2 illustrates the modified
compartment model. The sum of intermediary fatty acyl pools within the
mitochondria is represented as the 10th compartment (PAL). The rate of
LCFA transport across the mitochondrial membrane and into the fatty acid
compartment pool is defined as VPAL. At steady state, the rate of metabolic
flux from the fatty acid pool into the TCA cycle at citrate is equal to the
TCA cycle flux, VTCA, when palmitate is the sole substrate.
The revised model was formulated for a simultaneous, three-parameter
fit to the 13C enrichment curves of the 2- and 4-carbon positions of
glutamate as detected by NMR. Ten differential equations were used to
describe the compartment model, as shown below. Other compartments are
handled similarly, as previously described (Yu et al., 1995, 1997). Non-
linear least-square fitting of the model to 13C-NMR data of glutamate 2-
and 4-carbon enrichment using the Levenberg-Marquardt method (MAT-
LAB, The MathWorks Inc., Natick, MA) provides TCA cycle flux (VTCA),
FIGURE 1 Schematic representation of palmitate and butyrate uptake
and incorporation into the TCA cycle. 13C from labeled palmitate enters the
first span of the TCA cycle as acetyl-CoA, then labels -ketoglutarate, and
exchanges with the glutamate pool to produce [4-13C] glutamate, as shown.
Recycling of the label through the second span of the TCA cycle then
enriches both the 2- and 3-carbon positions with equal probability. Oxi-
dation of unlabeled butyrate reduces the 13C enrichment of glutamate from
labeled palmitate.
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the interconversion rate between cytosolic glutamate and mitochondrial
-ketoglutarate (F1), and the transport rate of LCFA into the mitochondria
before oxidation (Vpal).
Differential equations describing the pre-steady-state 13C labeling of
each metabolite pool of the TCA cycle are listed here for the metabolism
of palmitate. PAL is the fractional enrichment level of the mitochondrial
fatty acid pool. (i.e., PAL [13C-fatty acid pool of the mitochondria]/[total
fatty acid pool of mitochondria]. Fp is the fractional enrichment of the
labeled palmitate substrate (100%). CIT4 is the fractional enrichment level
of 13C at the 4-carbon position of citrate (i.e., CIT4  [(4-13C)CIT]/[CIT])
see Yu et al., 1995, 1997 for additional detail). The equation describing
malate enrichment includes anaplerotic and cataplerotic effects (Yu et al.,
1995, 1997).
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Statistical analysis
Data set comparisons were performed with Student’s unpaired, two-tailed
t-test. Differences in mean values were considered statistically significant
at a probability level of 5% (p  0.05).
RESULTS
Physiological function
Contractile function was similar in both groups of hearts.
Before the start of each protocol, hearts initially developed
a rate-pressure-product (RPP) of 20,000  4200 mm Hg
beats/min with glucose as the sole substrate. Substrate was
then switch as outlined above. For hearts perfused with
buffer containing 0.5 mM palmitate (n  4), RPP was
16,000 3500 (mm Hg beat/min), and hearts perfused with
buffer containing 0.5 mM palmitate plus 0.08 mM butyrate
(n  4) developed an RPP of 14,300  1800 (NS). Oxygen
consumption with palmitate alone was 21.07  7.42 mol/
min/g dw, and 18.7 9.8 (NS) with palmitate plus butyrate.
The ratio of wet to dry heart mass was the same for either
group; wet/dry  9:1.
Dynamic 13C-NMR data
Proton-decoupled 13C spectra of an isolated heart perfused
with [2,4,6,8,10,12,14,16-13C8] palmitate are shown in Fig.
3. Peak assignments include glutamate carbons C2, C4, and
C3 at 56, 34, and 28 ppm, respectively. Fig. 4 shows the
averaged time course of glutamate carbons C2 and C4
enrichment (mean SD) for both experimental groups. The
fit of the kinetic model to the enrichment data is shown as
the solid curves in Fig. 4.
The incorporation of 13C-labeled palmitate into the en-
dogenous triglyceride pool is also apparent in the 13C-NMR
spectra of Fig. 3. The broad (5 ppm) resonance centered at
31 ppm corresponds to five of the eight labeled carbons of
FIGURE 2 Compartment model of metabolic intermediates used in TCA
flux analysis of palmitate oxidation. The PAL compartment represents the
sum of the fatty acid intermediates within the mitochondria. In addition:
CIT, citrate; KG, -ketoglutarate; GLU, glutamate; MAL, malate; OAA,
oxaloacetate; ASP, aspartate. VPAL is the flux of long chain fatty acid
transport into the mitochondria, VTCA is the TCA cycle flux, and F1 is the
interconversion rate between -ketoglutarate and glutamate. F2 is set equal
to F1 (Yu et al., 1995, 1997).
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palmitate. Assignment of labeled triglyceride to the reso-
nance at 31 ppm is based on a high-resolution 13C-NMR
spectrum of the labeled palmitate (not shown) and TLC-MS
analysis of lipid extracts prepared from the heart samples.
Fatty acid transport and oxidation rates
Fig. 5 illustrates the relationship between LCFA entry into
mitochondria and TCA cycle rates from kinetic analysis of
the isotope enrichment curves. For hearts oxidizing palmi-
tate alone, TCA cycle flux was eight times the rate of
palmitate transport: VTCA  7.8  1.0 mol/min/g dw; and
VPAL  1.0  0.2 mol/min/g dw. The rate of palmitate
oxidation can be calculated from the TCA cycle flux and the
fraction of acetyl-CoA enriched from labeled palmitate (Fc
 92%) (palmitate oxidation  VTCA 
 Fc/8). The denom-
inator, eight, accounts for one molecule of palmitate pro-
viding eight molecules of acetyl-CoA that enter the TCA
cycle. In this protocol, the rate of palmitate oxidation is 0.9
mol/min/g dw. While palmitate oxidation can be measured
by conventional 14C/3H methods in intact beating hearts,
palmitate uptake (VPAL) and TCA cycle flux (VTCA) cannot.
This is the first study to report all three rates for the same
intact functioning heart.
In the second experimental group, fatty acid oxidation
was perturbed by the presence of an SCFA, butyrate, to
uncouple LCFA transport from the oxidation rate in the
mitochondria (VTCA). As shown in Fig. 5, the ratio of TCA
cycle flux to LCFA transport was perturbed, increasing
significantly (12:1) relative to hearts oxidizing palmitate as
the sole substrate (8:1). VTCA was 11.2  0.5 mol/min/g
dw, and VPAL was 0.9  0.1 mol/min/g dw. The increase
in VTCA (p 0.05) is consistent with the regulated oxidation
of SCFA. The calculated rate of palmitate oxidation is 0.8
mol/min/g dw.
The third parameter, exchange between -ketoglutarate
and glutamate (F1), was not affected by the change in
substrate availability. In hearts oxidizing palmitate, F1 was
2.6  0.5 mol/min/g dw, and in hearts oxidizing palmitate
plus butyrate F1 was 2.9  1.5 (p  0.05).
FIGURE 3 Selected 13C spectra from a dynamic data set obtained from
an isolated rabbit heart perfused with 0.5 mM [2,4,6,8,10,12,14,16-13C8]
palmitate. Peak assignments are glutamate carbon-2 (GLU-C2), glutamate
carbon-3 (GLU-C3), and glutamate carbon-4 (GLU-C4). Resonances de-
tected at 30 and 15 ppm correspond to enrichment of triglycerides.
FIGURE 4 Time course of glutamate 13C enrichment and kinetic anal-
ysis. The first 15 min of C2 enrichment are not shown due to low
enrichment levels below detectable concentrations that do not contribute
significantly to the kinetic fit. Solid circles, glutamate C4 enrichment; open
circles, glutamate C2 enrichment; solid lines, least-squares fitting of the
model to enrichment curves. (A) Palmitate group; (B) palmitate plus
butyrate group.
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Acetyl-CoA enrichment
The fraction of 13C-enriched acetyl-CoA entering the TCA
cycle (Fc) was determined from high-resolution
13C-NMR
spectra (Malloy et al., 1989). As expected, Fc values from
hearts oxidizing palmitate plus butyrate were significantly
lower (54% enrichment) compared to hearts oxidizing
palmitate (92%). This is consistent with unlabeled butyrate
being incorporated into the acetyl-CoA pool. The anaplero-
sis-to-citrate synthase ratio (y) was 0.34  0.06 in the
palmitate group and 0.29  0.05 in the palmitate plus
butyrate group (p  0.05).
Metabolite content
Steady-state metabolite contents are listed in Table 1. -Ke-
toglutarate, aspartate, and glutamate were not statistically
different between experimental groups (p  0.05). Citrate
was significantly higher in hearts oxidizing both palmitate
and butyrate.
Triglyceride content and enrichment
Triglyceride content was not statistically different between
experimental groups: 29.6  2.6 mol/g dw in hearts oxidiz-
ing palmitate alone, and 23.6  5.7 in hearts oxidizing both
palmitate and butyrate (p 0.05). Table 2 provides a list of the
major fatty acyl groups composing the triglyceride pool.
Hearts perfused with buffer containing labeled palmitate in-
corporated the LCFA into the endogenous triglyceride pool.
From MS analysis 8% of the triglyceride pool (or 22 4% of
the C16:0 palmitate isomer pool) contained acyl chains from
the exogenous [2,4,6,8,10,12,14,16-13C8] palmitate. In hearts
oxidizing both labeled palmitate and unlabeled butyrate, there
was no greater accumulation of palmitate in the triglyceride
pool. Nine percent of the acyl groups in the triglyceride pool
(or 24 7% of the C16:0 palmitate isomer pool) was from the
labeled palmitate.
DISCUSSION
This study is the first to elucidate the rate-determining
component of LCFA entry into mitochondria in the intact
beating heart, and to distinguish this transport process from
the oxidative activity of the TCA cycle. We also determine
substrate oxidation rate and assess the competitive oxidation
of long and short chain fatty acid substrates. Although
others have examined substrate oxidation and competition
by conventional 14C/3H radiotracer techniques (Belke et al.,
1999; Crass et al., 1969; Lopaschuk et al., 1986, 1997;
Oram et al., 1973), such measurements do not distinguish
between LCFA transport and TCA cycle activity as distinct
components of overall oxidation in the beating heart. Ad-
ditionally, we demonstrate the progressive incorporation of
FIGURE 5 Palmitate transport, VPAL, and TCA cycle flux, VTCA, for
hearts oxidizing either palmitate (cross-hatched bar) or palmitate  bu-
tyrate (solid bar). VTCA is eight times greater than VPAL in hearts oxidizing
palmitate. In hearts oxidizing both palmitate and butyrate, VTCA is signif-
icantly increased. This is consistent with increased substrate availability
(butyrate) which bypasses the regulatory proteins of palmitate oxidation.
( p  0.05.)
TABLE 1 Steady-state metabolite and triglyceride content in intact hearts
Perfusate Glutamate -Ketoglutarate Aspartate Citrate Triglyceride
Palmitate 20.0  2.9 0.16  0.09 5.13  0.93 0.49  0.35 29.6  2.6
Palmitate  Butyrate 22.3  6.1 0.42  0.34 5.79  1.44 1.84  1.05* 23.6  5.7
All values are means  SD. Metabolite concentrations are measured by enzymatic assays and listed as mol/g dry tissue wt.
*p  0.05.
TABLE 2 Fraction of long chain fatty acid isomers making
up the triglyceride pool as determined by GC-MS analysis
Long Chain Fatty Acid Isomer
Perfusate Condition
Palmitate
Palmitate 
Butyrate
C12:0 Laurate 0.00  0.01 0.00  0.01
C14:0 Myristate 0.03  0.01 0.03  0.01
C15:0 Pentadecanate 0.01  0.00 0.01  0.01
C16:0 Palmitate 0.35  0.03* 0.38  0.02†
C16:1 Palmitoleate 0.03  0.02 0.02  0.02
C17:0 Heptadecanoate 0.01  0.01 0.01  0.01
C18:0 Stearate 0.13  0.01 0.17  0.02
C18:1 Oleate 0.22  0.01 0.24  0.02
C18:2 Linoleate 0.19  0.01 0.13  0.04
C18:3 Linolenate 0.01  0.01 0.01  0.01
*22  4% of the C16:0 fatty acid pool was labeled palmitate.
†24  7% of the C16:0 fatty acid pool was labeled palmitate.
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the labeled substrate into the triglyceride pool. As the fate of
free fatty acids in the myocyte continues to be an important
aspect of energy metabolism in both normal and diseased
hearts, this work provides the basis for future studies on the
highly regulated processes of LCFA transport.
While previous efforts to monitor fatty acid metabolism
in the heart have relied on extracellular measurements, this
study provides new information on the regulatory role of
LCFA transport on oxidative metabolism via the first direct,
on-line observation of dynamic metabolic events inside the
myocytes of functioning hearts. This study also demon-
strates, for the first time, the practical application of stable
isotope kinetics in the elucidation of metabolite transport
rates that regulate oxidative flux in the intact, beating heart.
The administration of the novel, 13C-enriched long chain
fatty acid, [2,4,6,8,10,12,14,16-13C8] palmitate, enabled se-
quential acquisition of 13C-NMR spectra from the whole
heart. The result of this approach facilitated a simple kinetic
analysis based on the evolution of the detected enrichment
pattern that has been previously described for fuels with
shorter carbon chain length, but of less physiological sig-
nificance than that of palmitate (Lewandowski, 1992; Ro-
bitaille et al., 1993; Weiss et al., 1992).
TCA cycle flux and fatty acid transport in hearts
oxidizing palmitate
The TCA cycle flux was VTCA 7.8 1.0 mol/min/g dw,
and the transport rate of palmitate into the mitochondria was
VPAL  1.0  0.2. The ratio (VTCA/VPAL) nearly matches
the stoichiometric ratio predicted for palmitate conversion
to acetyl groups. That is, palmitate passes through -oxida-
tion seven times to produce eight molecules of acetyl-CoA.
Each molecule of acetyl-CoA is metabolized in one turn of
the TCA cycle. Thus, the TCA cycle rate should be eight
times the rate of palmitate transport when palmitate is the
sole substrate. The model accurately determined this ratio
from the fit to the NMR data.
As a separate entity, we find the rate of palmitate oxida-
tion is 0.9 mol/min/g dw. This value compares well with
the oxidative rate measured by conventional 14C/3H tech-
niques (0.2–1.3 mol/min/g dw) (Belke et al., 1999; Crass
et al., 1969; Lopaschuk and Barr, 1997; Lopaschuk et al.,
1986; Oram et al., 1973; Saddik et al., 1993). The rate
matches the rate of palmitate transport into the mitochondria
(VPAL). This match is expected under these steady-state
metabolic conditions. As previously stated, while palmitate
oxidation can be measured by 14C/3H methods, palmitate
transport (VPAL) and TCA cycle activity (VTCA) cannot.
TCA cycle flux and fatty acid transport in hearts
oxidizing palmitate and butyrate
Palmitate and butyrate, the long and short chain saturated
fatty acids used in these experiments, enter the mitochondria
through different processes. Unlike palmitate, butyrate does
not depend upon transport across the cell membrane by the
fatty acid transporter, activation in the extra-mitochondrial
space, or transport into the matrix by the carnitine shuttle
(CPT1, CPT2, and CAT). This SCFA readily crosses both
the sarcolemmal and mitochondrial membranes, and is ac-
tivated to the CoA ester in the matrix. Consequently, while
LCFA utilization may be tightly regulated by the activity of
the carnitine shuttle, SCFA bypass this control network. We
wanted to determine how bypassing this highly regulated
and rate-determining step would affect metabolic rates.
In hearts oxidizing both palmitate and butyrate, TCA
cycle flux was VTCA  11.2  0.5 mol/min/g dw and
palmitate transport was VPAL  0.9  0.1. The ratio (VTCA/
VPAL  12) is greater compared to hearts oxidizing palmi-
tate alone (VTCA/VPAL  8). The increase is consistent with
the oxidation of the second substrate, butyrate. A 41% drop
in the fractional enrichment of acetyl-CoA (Fc) also follows
oxidation of butyrate. Importantly, adding the second sub-
strate did not reduce the transport rate of palmitate into the
mitochondria, VPAL, despite constant oxygen consumption
and workload. This results provides important insight into
the transport processes regulating fatty acid oxidation.
There are a number of proposed mechanisms regulating
palmitate transport into the mitochondria. Oram et al.
(1973) have shown that when palmitate is provided as a sole
substrate and the concentration is raised from 0 to 0.4 mM,
uptake increases proportionately. As the level of exogenous
palmitate is raised from 0.6 to 1.2 mM, no further increase
in uptake is observed. It is proposed that the oxidation of the
fatty acid may be limited at high concentrations by either
the activity of the TCA cycle or the availability of cytosolic
CoA and carnitine (Oram et al., 1973). In our experiment,
butyrate does not require cytosolic carnitine or CoA. There-
fore, this regulatory mechanism is not expected to limit
palmitate transport. When we bypass this regulatory mech-
anism, we find TCA cycle activity increases. Thus, TCA
cycle flux may not limit palmitate oxidation at these con-
centrations.
Others have found that when palmitate is provided in
combination with pyruvate or glucose, there is a dramatic
increase in carnitine acetyltransferase activity and malonyl
CoA content (Lysiak et al., 1986; Saddik et al., 1993). A
subsequent drop in fatty acid oxidation is consistent with the
inhibitory effect of malonyl-CoA on CPT1. It is proposed
that the acetyl-CoA generated from pyruvate may be readily
accessible to this inhibitory pathway. On the contrary, Ly-
siak (1986) and Abdel-aleem et al. (1996) have shown that
the acetyl-CoA generated from the -oxidation of fatty
acids may not have the same access and may be preferen-
tially shuttled to the TCA cycle. Our data support their
results described for isolated mitochondria and myocytes.
We observe an increase in TCA cycle activity without an
inhibition of palmitate transport in hearts oxidizing only
fatty acids.
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Our results were observed at tightly controlled exogenous
fatty acid concentrations. At higher concentrations of bu-
tyrate (0.10 mM), we observed complete inhibition of
palmitate oxidation (VPAL  0, Fc  0). We hypothesize
that inhibition was not due to inhibition at CPT1, but rather
preferential utilization of mitochondrial CoA by butyrate to
the exclusion of palmitate.
Importantly, the purpose of our study was not to further
elucidate the feedback mechanisms acting on CPT1. The
intent was to examine the dynamic interactions of flux
coupling between LCFA transport and TCA rate. This study
is the first to report these rates for intact functioning heart.
Indeed, this study is an important prelude to in vivo MRS
studies because the in vivo heart oxidizes a menu of avail-
able fuels. The oxidative flux supported by alternate fuels
must be distinguished from the transport and entry rates of
the predominant fatty acid fuels for oxidative metabolism.
14C/3H radiotracer versus 13C-NMR
measurements of oxidative flux
With NMR we can detect and distinguish among TCA cycle
flux, LCFA transport, substrate oxidation, and metabolite
exchange between the mitochondria and cytosol. In con-
trast, with conventional 14C/3H radiotracer measurements,
only substrate oxidation and glycolysis rates are measure in
intact tissue (Lopaschuk and Barr, 1997). These measure-
ments are made by providing the heart with 14C or 3H
radio-labeled substrates. The rate of 14CO2/
3H2O release
provides a measure of the oxidation of a particular radio-
labeled carbon source. The experimental system must be
tightly sealed because measurements are made external to
the heart and CO2 could be lost as it passes from the
mitochondria to the CO2 trapping solution. This approach
does not lend itself well to in vivo studies. With 13C-NMR,
metabolic rates are assessed based on direct detection of
metabolite enrichment inside the cardiomyocytes of the
intact tissue. 13C-NMR can be done in vivo, and could be
advanced to give even more quantitative data on specific
enzymatic reactions of metabolism.
Long chain fatty acid oxidation and the
kinetic model
In formulating the kinetic model, the oxidation of LCFAs
requires the addition of a compartment that reflects the
rate-determining transport of LCFA across the mitochon-
drial membrane and the subsequent accumulation of fatty
acid intermediates in the mitochondria. Consideration was
given as to whether the intermediary fatty acid pools of the
mitochondria would affect the 13C enrichment rate of glu-
tamate. In the compartment model, the FA pool represents
the sum of the fatty acid intermediates between uptake at the
mitochondrial membrane and entry into the TCA cycle at
citrate. The concentration of the larger pools of metabolites
were taken from literature on hearts perfused under compa-
rable conditions; fatty acyl-CoA 0.10 mol/g dw (Lopa-
schuk et al., 1986; Whitmer et al., 1978), fatty acyl-carnitine
0.6 mol/g dw (Idell-Wenger et al., 1978; Lopaschuk et al.,
1990; Whitmer et al., 1978); and acetyl-CoA 0.2 mol/g dw
(Randle et al., 1970; Saddik et al., 1993). The effect of
possible variations or errors in these pool sizes, plus con-
tributions from the smaller intermediate metabolite pools of
-oxidation, were evaluated by sensitivity analysis with
500% changes in pool sizes. Results from kinetic simula-
tions showed that even the most dramatic changes in these
relatively small pool sizes will have minimal impact on the
labeling kinetics of glutamate.
CONCLUSIONS
In conclusion, sequential 13C-NMR spectra were obtained
from intact hearts supplied perfusate containing the long chain
fatty acid, palmitate, or palmitate co-infused with the short
chain fatty acid, butyrate. The use of [2,4,6,8,10,12,14,16-
13C8] palmitate, uniquely labeled at every other carbon, pro-
vided a means to monitor the rate-determining and competitive
oxidation of long chain versus short chain fatty acids. A kinetic
model was developed for the analysis of 13C enrichment data
to evaluate the transport rate of palmitate relative to the TCA
cycle flux. As expected, TCA cycle flux followed fatty acid
transport when palmitate was provided as the sole substrate.
When the transport of the LCFA was bypassed by the avail-
ability of a short chain fatty acid, TCA cycle activity increased
and LCFA transport remained constant. This result supports
the hypothesis that the products of -oxidation are preferen-
tially channeled to the TCA cycle, and away from mitochon-
drial efflux via carnitine acetyltransferase. These 13C-NMR
measurements are not only sensitive to TCA activity, as pre-
viously reported, but also to the highly regulated transport
processes that ultimately determine rates of long chain fatty
acid oxidation.
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